EluRyng vs. NuvaRing

EluRyng (etonogestrel and ethinyl estradiol ring) and NuvaRing (etonogestrel and ethinyl estradiol vaginal ring) are estrogen/progestin combination hormonal contraceptives (CHCs) in a flexible contraceptive vaginal ring indicated for use by women to prevent pregnancy.

Side effects of EluRyng and NuvaRing that are similar include changes in your menstrual periods, vaginal infections and irritation, vaginal itching or discharge, headache, nausea, vomiting, changes in weight, breast pain/discomfort/tenderness/swelling, abdominal pain, cramps, and decreased sex drive.

Side effects of EluRyng that are different from NuvaRing include migraine, mood changes (e.g., depression, mood swings, mood altered, affect lability), device-related events (e.g., expulsion/discomfort/foreign body sensation), painful menstrual periods, and acne.

Side effects of NuvaRing that are different from EluRyng include bloating, stomach cramps, changes in appetite, nervousness, dizziness, tired feeling, freckles or darkening of facial skin, increased hair growth, loss of scalp hair, and problems with contact lenses.

Both EluRyng and NuvaRing may interact with seizure medications, barbiturates, bosentan, St. John's wort, antifungal medications, drugs to treat hepatitis C or HIV/AIDS, acetaminophen, and tizanidine.

EluRyng may also interact with felbamate, griseofulvin, rifampicin, topiramate, rifabutin, rufinamide, aprepitant, grapefruit juice, cyclosporine, prednisolone, theophylline, clofibric acid, morphine, salicylic acid, temazepam, lamotrigine, and thyroid hormone replacement therapy.

NuvaRing may also interact with antibiotics, ascorbic acid (vitamin C), atorvastatin, dantrolene, tizanidine, and tranexamic acid.

Side effects of EluRyng include:

• irregular uterine bleeding,
• vaginitis,
• headache (including migraine),
• mood changes (e.g., depression, mood swings, mood altered, depressed mood, affect lability),
• device-related events (e.g., expulsion/discomfort/foreign body sensation),
• nausea,
• vomiting,
• vaginal discharge,
• weight gain,
• vaginal discomfort,
• breast pain/discomfort/tenderness,
• painful menstrual periods/cramps,
• abdominal pain,
• acne, and
• decreased libido

Common side effects of NuvaRing include:

• vaginal infections and irritation,
• vaginal itching or discharge,
• headache,
• nausea,
• vomiting,
• bloating,
• stomach cramps,
• changes in weight or appetite,
• breast pain/tenderness/swelling,
• headache,
• nervousness,
• dizziness,
• tired feeling,
• freckles or darkening of facial skin,
• increased hair growth,
• loss of scalp hair,
• problems with contact lenses,
• vaginal itching or discharge,
• changes in your menstrual periods, and
• decreased sex drive

EluRyng (etonogestrel and ethinyl estradiol ring) is an estrogen/progestin combination hormonal contraceptive (CHC) indicated for use by women to prevent pregnancy. EluRyng is available as a generic.

NuvaRing (NEW-vah-ring) is a flexible birth control vaginal ring used to prevent pregnancy.

NuvaRing contains a combination of a progestin and estrogen, 2 kinds of female hormones. Birth control methods that contain both an estrogen and a progestin are called combination hormonal contraceptives (CHCs).

EluRyng may interact with other medicines such as:

• phenytoin,
• barbiturates,
• carbamazepine,
• bosentan,
• felbamate,
• griseofulvin,
• oxcarbazepine,
• rifampicin,
• topiramate,
• rifabutin,
• rufinamide,
• aprepitant,
• St. John's wort,
• itraconazole,
• voriconazole,
• fluconazole,
• grapefruit juice,
• ketoconazole,
• HIV protease inhibitors,
• HCV protease inhibitors,
• non-nucleoside reverse transcriptase inhibitors (NNRTIs),
• cyclosporine,
• prednisolone,
• theophylline,
• tizanidine, voriconazole,
• acetaminophen,
• clofibric acid,
• morphine,
• salicylic acid,
• temazepam,
• lamotrigine,
• thyroid hormone replacement therapy, and
• HCV drug combinations containing ombitasvir/paritaprevir/ritonavir, with or without dasabuvir

Tell your doctor all medications and supplements you use.

NuvaRing may interact with bosentan, antibiotics, antifungal medications, drugs to treat hepatitis C or HIV/AIDS, phenobarbital and other barbiturates, St. John's wort, seizure medications, acetaminophen, ascorbic acid (vitamin C), atorvastatin, dantrolene, vaginal miconazole, tizanidine, or tranexamic acid.

The dose of EluRyng is one EluRyng inserted in the vagina. The ring must remain in place continuously for three weeks, followed by a one-week ring-free interval.

Nuvaring is inserted once a month for 3 weeks and then removed. A new ring is inserted after a 7 day break. NuvaRing may interact with bosentan, antibiotics, antifungal medications, drugs to treat hepatitis C or HIV/AIDS, phenobarbital and other barbiturates, St. John's wort, seizure medications, acetaminophen, ascorbic acid (vitamin C), atorvastatin, dantrolene, vaginal miconazole, tizanidine, or tranexamic acid. Tell your doctor all medications and supplements you use. Do not use NuvaRing if you are pregnant. NuvaRing can cause birth defects. Tell your doctor right away if you become pregnant, or if you miss two menstrual periods in a row. If you have recently had a baby, wait at least 4 weeks before using NuvaRing. The hormones in NuvaRing can pass into breast milk and may harm a nursing baby. NuvaRing may also slow breast milk production. Breastfeeding while using NuvaRing is not recommended.